We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB (MPSIIIB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03315182
Recruitment Status : Enrolling by invitation
First Posted : October 20, 2017
Last Update Posted : November 6, 2017
Abeona Therapeutics, Inc
Information provided by (Responsible Party):
Kevin Flanigan, Nationwide Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : October 2020
  Estimated Study Completion Date : October 2020